Target intelligence / Profile preview

Quinone binding site of the cytochrome bc1 complex (Qo site)

Target
Qo site
Molecular classification
Enzyme, Oxidoreductase, Electron transport chain complex, Membrane protein
01

Overview

The quinone binding site of the cytochrome bc1 complex (Complex III) in Neisseria gonorrhoeae is a critical component of the bacterial respiratory chain, facilitating the transfer of electrons from ubiquinol to cytochrome c. This process, known as the Q-cycle, involves two distinct catalytic sites: the quinol oxidation (Qo) site and the quinone reduction (Qi) site, both located within the cytochrome b subunit. In N. gonorrhoeae, this complex is essential for maintaining the proton motive force required for ATP synthesis and supporting growth under the microaerobic and anaerobic conditions encountered during infection. Recent research has identified the Qo site as a highly selective therapeutic target for treating multidrug-resistant gonorrhea. Small molecules such as 2-nonyl-4-quinolone N-oxide (NQNO) and its derivatives competitively inhibit this site, leading to rapid ATP depletion and the activation of endogenous toxin-antitoxin systems, such as the Zeta1 toxin, which results in bacterial cell death. Importantly, these inhibitors can demonstrate high selectivity for the gonococcal enzyme over human mitochondrial counterparts, offering a path for narrow-spectrum antibiotic development.

Other names
Qo siteQp siteQuinol oxidation siteUbiquinol oxidation siteQi siteQn siteComplex III quinone binding siteQuinol-binding site of cytochrome bc1
02

Mechanism of action

Inhibition of electron transfer by competitively blocking the quinol oxidation (Qo) site of the cytochrome bc1 complex, which disrupts the Q-cycle, halts the respiratory chain, and induces lethal oxidative stress and toxin release.

03

Biological functions

Cellular respirationElectron transportProton motive force generationATP synthesisAnaerobic respirationRedox homeostasis
04

Disease associations

Infection
05

Safety considerations

Potential off-target inhibition of human mitochondrial cytochrome bc1 complex (Complex III)Development of resistance through mutations in the petB gene (encoding cytochrome b)Potential for cross-resistance with other respiratory inhibitors
06

Interacting drugs

2-nonyl-4-quinolone N-oxide (NQNO)

5 more in the full profile.

07

Biomarkers

Intracellular ATP levelsNADH/NAD+ ratioReactive oxygen species (ROS) productionZeta1 toxin activation

Beyond the preview

Go deeper on Quinone binding site of the cytochrome bc1 complex (Qo site).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Quinone binding site of the cytochrome bc1 complex (Qo site).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call